CRSP

Market

CRISPR Therapeutics AG [CRSP] Revenue clocked in at $38.05 million, up 69.23% YTD: What’s Next?

Brandon Evans

CRISPR Therapeutics AG [NASDAQ: CRSP] gained 8.72% or 6.16 points to close at $76.78 with a heavy trading volume of ...

Companies

JP Morgan slashes price target on CRISPR Therapeutics AG [CRSP] – find out why.

Misty Lee

CRISPR Therapeutics AG [NASDAQ: CRSP] jumped around 6.66 points on Thursday, while shares priced at $72.82 at the close of ...

DBT News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.